Moderna, mRNA and bird flu

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...
HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.
Mango was instrumental to the effort to develop Covid-19 vaccines and treatments, and was working on the Trump transition ...
Moderna, a leader in mRNA medicine ... The Secretary of Health and Human Services (HHS) has the power to authorize unapproved medical products if an emergency has been designated by the U.S ...
CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the developme ...